{"id":11734,"date":"2025-07-26T04:24:11","date_gmt":"2025-07-26T02:24:11","guid":{"rendered":"https:\/\/valintermed.com\/?p=11734"},"modified":"2025-07-26T04:24:11","modified_gmt":"2025-07-26T02:24:11","slug":"keratomalyatsiya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/keratomalysis\/","title":{"rendered":"Keratomalacia"},"content":{"rendered":"
<\/div>\n

Keratomalacia is a rare disorder characterized by abnormal softening of the cornea on the surface of the eyeball, which can lead to vision impairment and, in some cases, complete vision loss. This condition is most often caused by autoimmune diseases, metabolic disorders, or prolonged exposure to adverse physical factors such as ultraviolet radiation. In the initial stages, patients may not experience noticeable symptoms, but as the disease progresses, there is a marked decrease in visual acuity, discomfort, and inflammation in the eye tissue. Treatment of keratomalacia should be comprehensive and include both conservative and surgical methods aimed at restoring the structure of the cornea and improving visual function.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n